Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Conference News ESC 2023

ESC Cardiomyopathy Guidelines Span Range of Phenotypes

Yael L. Maxwell

August 31, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2022

Shelley Wood

January 31, 2022

News Daily News

Most Cardiac Complications From MIS-C Resolve Within Months

Shelley Wood

July 15, 2021

More Evidence Links Myocarditis to mRNA COVID-19 Vaccines

News Daily News

From the Dress Rehearsal to Closing Night: Lessons in Humility and Hope

Ankur Kalra

June 15, 2021

News Daily News

Large Registry Reassures on COVID-19’s CV Impact

Caitlin E. Cox

April 22, 2021

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

News Daily News

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Michael O'Riordan

February 26, 2021

News Features

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

Todd Neale

November 02, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

Shelley Wood

July 31, 2020

News Daily News

COVID-19’s Kawasaki-Like MIS-C Diagnosis Is Cropping Up in Adults

Shelley Wood

July 22, 2020

News Daily News

High TEE Injury Rate in Structural Heart Interventions Warrants Caution

Yael L. Maxwell

June 24, 2020

News Daily News

COVID-19-Related Inflammatory Syndrome in Kids Needs Cardiac Follow-up

Shelley Wood

June 10, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2020

Shelley Wood

June 04, 2020

News Daily News

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

Michael O'Riordan

January 10, 2020

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

July 15, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Daily News

Virtual Reality Begins to Make Its Mark on Cardiovascular Medicine

Caitlin E. Cox

June 25, 2018

Advertisement

January 2025 Dispatch for the CV Team

ESC Cardiomyopathy Guidelines Span Range of Phenotypes

TCTMD’s Top 10 Most Popular Stories for January 2022

Most Cardiac Complications From MIS-C Resolve Within Months

More Evidence Links Myocarditis to mRNA COVID-19 Vaccines

From the Dress Rehearsal to Closing Night: Lessons in Humility and Hope

Large Registry Reassures on COVID-19’s CV Impact

March 2021 News Roundup

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

TCTMD’s Top 10 Most Popular Stories for July 2020

COVID-19’s Kawasaki-Like MIS-C Diagnosis Is Cropping Up in Adults

High TEE Injury Rate in Structural Heart Interventions Warrants Caution

COVID-19-Related Inflammatory Syndrome in Kids Needs Cardiac Follow-up

TCTMD’s Top 10 Most Popular Stories for May 2020

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Virtual Reality Begins to Make Its Mark on Cardiovascular Medicine

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content